COMMUNIQUÉS West-GlobeNewswire

British Columbia Psychological Association opposes the classification of psychological and psychiatric conditions as “minor injuries” in ICBC legislation
04/05/2018
VANCOUVER, British Columbia, May 04, 2018 (GLOBE NEWSWIRE) -- The British Columbia Psychological Association opposes the inclusion of “a psychological or psychiatric condition” in the definition of “minor injury” in [...]
CellaVision AB: Bulletin from AGM held on May 4, 2018
04/05/2018
Press release 4 May 2018 Bulletin from the Annual General Meeting of CellaVision AB (publ) held on May 4, 2018 At CellaVision's Annual General Meeting, held in Lund today, May 4, 2018, The meeting resolved upon the [...]
Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2018
04/05/2018
Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2018 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
Essilor : Nombre total de droits de vote et d'actions composant le capital social au 30 avril 2018
04/05/2018
Nombre total de droits de vote et d'actions composant le capital social au 30 avril 2018 (Article L.233-8 II du Code de Commerce et les articles 221-1 et 223-16 du Règlement Général de l'AMF) Charenton-le-Pont, France ( [...]
Colibri Heart Valve Continues Enrollment in Clinical Feasibility Study of Second-Generation TAVI System
04/05/2018
EuroPCR Exhibit will Highlight Package-to-Patient Design Broomfield, CO, May 04, 2018 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC , a privately held emerging medical device company, today announced that the Colibri [...]
ASLAN Pharmaceuticals Prices Initial Public Offering of Its American Depositary Shares
04/05/2018
SINGAPORE, May 04, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals Limited (TPEx:6497.TT), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in the [...]
Obalon Schedules First Quarter 2018 Financial Results Conference Call for May 10, 2018 at 5:00 p.m. Eastern Time
04/05/2018
SAN DIEGO, May 04, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon [...]
Delcath to Present at the RHK Capital 2018 Disruptive Growth and Healthcare Conference
04/05/2018
NEW YORK, May 04, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces that Jennifer K. Simpson, Ph [...]
Celsion Corporation to Hold First Quarter 2018 Financial Results Conference Call on Friday, May 11, 2018
04/05/2018
LAWRENCEVILLE, N.J., May 04, 2018 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) announced today that the Company will host a conference call to discuss financial results for the quarter ended March 31, 2018 and [...]
GBT Announces New Employment Inducement Grants
04/05/2018
SOUTH SAN FRANCISCO, Calif., May 04, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT ) today announced that on May 1, 2018, the compensation committee of the Company’s board of directors [...]
Verona Pharma to Present at Bio€quity Europe 2018
04/05/2018
LONDON, May 04, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq: VRNA ) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
Tetra BioPharma Signs Second Commercialization Deal with Azevedos Industria Farmaceutica, S.A. for the Lead RX product PPP001
04/05/2018
OTTAWA, May 04, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX-V: TBP ) (OTCQB:TBPMF), and Azevedos Indústria Farmacêutica, S.A. announced that they have signed a binding term sheet for [...]
Genocea to Host First Quarter 2018 Financial Results Conference Call & Webcast on May 10, 2018 at 9 a.m. ET
04/05/2018
CAMBRIDGE, Mass., May 04, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. ( NASDAQ:GNCA), a biopharmaceutical company developing neoantigen cancer vaccines, today announced that it will host a conference call and [...]
Zogenix to Release First Quarter 2018 Financial Results and Host Conference Call and Webcast on May 9
04/05/2018
EMERYVILLE, Calif., May 04, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX ), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that it [...]
Capricor Therapeutics to Present First Quarter 2018 Financial Results and Corporate Update on May 10
04/05/2018
LOS ANGELES, May 04, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR ), a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment of [...]
MediWound to Host First Quarter 2018 Financial Results Conference Call on May 10 at 8:30 a.m. Eastern Time
04/05/2018
YAVNE, Israel, May 04, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD ), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, [...]
Lexicon Pharmaceuticals Announces Publication of New XERMELO® (Telotristat Ethyl) Data in Clinical Therapeutics
04/05/2018
Significant Dose-Dependent Effects on Changes in Weight Gain and Biochemical and Metabolic Parameters Improvements in Diarrhea Severity and Nutritional Status THE WOODLANDS, Texas, May 04, 2018 (GLOBE NEWSWIRE) -- [...]
Intra-Cellular Therapies Announces Presentations on Lumateperone at Two Upcoming Medical Conferences
04/05/2018
NEW YORK, May 04, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, announced [...]
Avinger to Announce First Quarter 2018 Financial Results on May 14, 2018
04/05/2018
REDWOOD CITY, Calif., May 04, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it will release its financial [...]

Pages